Delta variant of coronavirus Current Affairs, GK & News

Covaxin approved for emergency use in 2–18-year-olds

The Subject Expert Committee on Covid-19 has approved the “emergency use” of Bharat Biotech’s Covaxin vaccine for children aged between 2-18 years old. Key Points Phase-2 and Phase-3 trials of the Covaxin vaccine by Hyderabad-based Bharat Biotech on children below the age of 18 years in the months of September. Trial data was submitted to ..